Knowledge Center

Article / Jun 08, 2009

ËÄÉ«AV Shapes China Manufacturing Site

Authors:
Source:
C&EN, 8 June, 2009

ËÄÉ«AV may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what ËÄÉ«AV did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai.

Related links

Also in the Knowledge Center

Related Content

Drug delivery platforms

ËÄÉ«AV has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more

Development

ËÄÉ«AV offers a full range of development services in particle engineering to provides optimal solutions for your drug product.

Page
Read more

What we do

ËÄÉ«AV is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more